Supply Chain
Long wait times, crowded waiting rooms, and frustrated staff are often symptoms of inefficient workflows driven by physical space constraints.…
Northwestern Medicine is testing drone deliveries at Delnor Hospital in Geneva, Ill., in collaboration with Valqari.
The Administration for Strategic Preparedness and Response, an HHS agency, is providing $44 million to bolster the U.S. public health supply chain.
Baxter has implemented new allocation levels for several U.S. IV product groups, effective Nov. 26, as part of recovery efforts at its North Carolina manufacturing site.
President-elect Donald Trump's plan to impose tariffs on imported goods is expected to affect the prices of approximately 75% of medical devices marketed in the U.S., according to consulting firm GlobalData's Medsource Database, Medical Device Network reported Nov. 22.
The FDA's Center for Devices and Radiological Health announced a pilot program designed to improve the timeliness of communications regarding high-risk medical device recalls.
Medical device recalls, whether voluntary or mandated, are crucial for ensuring patient safety.
Baxter announced the release of its first 1-liter IV solutions manufactured post-hurricane, marking a significant step in addressing the ongoing IV shortage.
The American Medical Manufacturers Association is calling on Congress to quickly reauthorize the Pandemic and All-Hazards Preparedness Act before the end of the 118th Congressional Session in January 2025.
Medtronic reported its second-quarter financial results for the fiscal year 2025, showing a 5.3% increase in total revenue, reaching $8.4 billion.
As the medical device industry looks ahead to potential policies under the new administration, key decisions could shape the future of innovation, regulation and reimbursement in this sector.